Cancer Study Sees Tailored Treatment, Outcome Boost with Comprehensive Genomic Profiling
Investigators tracked clinical and treatment outcomes for advanced cancer patients who had tumor testing with an in-house assay developed by Providence Health.
The Vega sequencer, launched at last week's ASHG annual meeting, is aimed at researchers who desire to do HiFi long-read sequencing but previously could not afford the high-throughput Revio platform.
Ambry Updates Hereditary Cancer Risk Panels With Eye Toward Gene-Disease Validity, Guidelines
Premium
The panels assess genes with strong disease links and clinical management guidelines, but the firm offers limited-evidence genes as an add-on option.
At the American Society of Human Genetics annual meeting last week, the company highlighted new spatial transcriptomics and proteomics analysis workflows.
Centogene to Sell Business to Private Equity Group for €8.7M, Liquidate Remaining Subsidiaries
Charme Capital Partners will acquire complete ownership of Centogene GmbH and will assume Centogene's loan from Oxford Finance.